The table below shows Dare Bioscience, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$152.46K
$2.26K
-
$25.43K
$41.69K
$22.44K
Cost of revenue
$242.32K
-
-
$0.00
-
-
Gross profit
-
-
-
-
-
-
R&D
$660.46K
$1.18M
$1.43M
$2.30M
$2.68M
$4.93M
SG&A
DARE annual revenue (10-K history)
Dare Bioscience, Inc. reported annual revenue of $1.03M for fiscal year 2025. That is up 10429.4% from $9.78K in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $625.00K (FY 2012) to $1.03M. Figures come from the company's audited annual reports as filed with the SEC.